These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 19842076)

  • 21. Pegaptanib sodium for occult choroidal neovascularization in neovascular age-related macular degeneration: a prospective case series.
    Atmani K; Coscas F; Coscas G; Soubrane G
    Eye (Lond); 2009 May; 23(5):1150-4. PubMed ID: 18636083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pegaptanib sodium for the treatment of neovascular age-related macular degeneration: a review.
    Kourlas H; Schiller DS
    Clin Ther; 2006 Jan; 28(1):36-44. PubMed ID: 16490578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration.
    Rosenfeld PJ; Heier JS; Hantsbarger G; Shams N
    Ophthalmology; 2006 Apr; 113(4):623.e1. PubMed ID: 16581423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pegaptanib (Macugen): treating neovascular age-related macular degeneration and current role in clinical practice.
    Vavvas D; D'Amico DJ
    Ophthalmol Clin North Am; 2006 Sep; 19(3):353-60. PubMed ID: 16935210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effectivity and safety of bevacizumab intravitreal injections for exudative age-related macular degeneration treatment--6 months observations].
    Małgorzata F
    Klin Oczna; 2010; 112(7-9):213-6. PubMed ID: 21121123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of vascularised serous pigment epithelium detachment in AMD - observations after changing the intravitreal agent due to lack of response].
    Lommatzsch AP; Heimes B; Gutfleisch M; Spital G; Zeimer M; Pauleikhoff D
    Klin Monbl Augenheilkd; 2008 Oct; 225(10):874-9. PubMed ID: 18951308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pegaptanib for neovascular age-related macular degeneration.
    Maberley D
    Issues Emerg Health Technol; 2005 Dec; (76):1-4. PubMed ID: 16544440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
    Retina; 2007; 27(4):432-8. PubMed ID: 17420694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial.
    Singerman LJ; Masonson H; Patel M; Adamis AP; Buggage R; Cunningham E; Goldbaum M; Katz B; Guyer D
    Br J Ophthalmol; 2008 Dec; 92(12):1606-11. PubMed ID: 18614570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Newly diagnosed exudative age-related macular degeneration treated with pegaptanib sodium monotherapy in US community-based practices: medical chart review study.
    Weber PA; Wirostko BM; Xu X; Goss TF; Zlateva G
    BMC Ophthalmol; 2010 Feb; 10():2. PubMed ID: 20144224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
    Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U
    Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-VEGF treatment patterns for neovascular age-related macular degeneration among medicare beneficiaries.
    Lad EM; Hammill BG; Qualls LG; Wang F; Cousins SW; Curtis LH
    Am J Ophthalmol; 2014 Sep; 158(3):537-43.e2. PubMed ID: 24857687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration.
    Rosenfeld PJ; Schwartz SD; Blumenkranz MS; Miller JW; Haller JA; Reimann JD; Greene WL; Shams N
    Ophthalmology; 2005 Jun; 112(6):1048-53. PubMed ID: 15885778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of neovascular age-related macular degeneration with intravitreal bevacizumab: efficacy of three consecutive monthly injections.
    Melamud A; Stinnett S; Fekrat S
    Am J Ophthalmol; 2008 Jul; 146(1):91-5. PubMed ID: 18455144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ranibizumab for exudative age-related macular degeneration in eyes previously treated with alternative vascular endothelial growth factor inhibitors.
    Ehlers JP; Spirn MJ; Shah CP; Fenton GL; Baker PS; Regillo CD; Ho AC
    Ophthalmic Surg Lasers Imaging; 2010; 41(2):182-9. PubMed ID: 20307035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pegaptanib combined with intravitreal injection of moxifloxacin as treatment of wet macular degeneration.
    Bennett MD; Yee W; Bryan JS
    Retina; 2008; 28(7):976-80. PubMed ID: 18698300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optical Coherence Tomography Angiography of Type 1 Neovascularization in Age-Related Macular Degeneration.
    Kuehlewein L; Bansal M; Lenis TL; Iafe NA; Sadda SR; Bonini Filho MA; De Carlo TE; Waheed NK; Duker JS; Sarraf D
    Am J Ophthalmol; 2015 Oct; 160(4):739-48.e2. PubMed ID: 26164826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration.
    Emerson MV; Lauer AK; Flaxel CJ; Wilson DJ; Francis PJ; Stout JT; Emerson GG; Schlesinger TK; Nolte SK; Klein ML
    Retina; 2007; 27(4):439-44. PubMed ID: 17420695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visual improvement following intravitreal bevacizumab (Avastin) in exudative age-related macular degeneration.
    Yoganathan P; Deramo VA; Lai JC; Tibrewala RK; Fastenberg DM
    Retina; 2006; 26(9):994-8. PubMed ID: 17151485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Compassionate use of intravitreal pegaptanib in patients with age-related macular degeneration.
    Ricci F; Missiroli F; Cedrone C; Grossi M; Regine F
    Semin Ophthalmol; 2010; 25(1-2):16-20. PubMed ID: 20507192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.